Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GDRX · against 472 other Healthcare companies of similar size
Ranked #404 of 473 · scores higher than 15% of peers · safety percentile 15
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)51 peers with a safety percentile of 10–19, including GDRX · Click a bar to see the companies
Mainly because of its beta, debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GDRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 446 reported | 0.83× | 0.20× | 19% | 33% | |
| BetaLower is better · 446 reported | 1.69 | 0.49 | 7% | 33% | |
| Current ratioHigher is better · 459 reported | 1.38× | 2.88× | 19% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 400 | 11.1B BRL (≈$2.0B) | 16 | 60 | |
| 401 | 1.5B USD | 16 | 65 | |
| 402 | 885M USD | 15 | 33 | |
| 403 | 5.9B CNY (≈$824M) | 15 | 26 | |
| 404 | 1.2B USD | 15 | 39 | |
| 405 | 1.8B USD | 15 | 52 | |
| 406 | 730M USD | 15 | 11 | |
| 407 | 8.9B CNY (≈$1.2B) | 15 | 42 | |
| 408 | 15.6B DKK (≈$2.3B) | 15 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score